Since a biomarker’s predictive strength in a cancer depends in part on its variability, Fig. 2c can support educated guesses on the performance of each putative predictive biomarker in any given tumor type (in the context of PD-1/PD-L1 pathway blockade). The gene discussed is CD274; the disease is cancer.